Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-22-018769
Filing Date
2022-05-12
Accepted
2022-05-12 09:00:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 ny20004028x3_424b3.htm 424B3 126540
  Complete submission text file 0001140361-22-018769.txt   127843
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264585 | Film No.: 22915936
SIC: 2834 Pharmaceutical Preparations